Latest News on CI

Financial News Based On Company


Advertisement
Advertisement

The Cigna Group Deepens Community Impact Strategy, Adds New Commitment Supporting People with Complex Health Conditions

https://www.streetinsider.com/PRNewswire/The+Cigna+Group+Deepens+Community+Impact+Strategy%2C+Adds+New+Commitment+Supporting+People+with+Complex+Health+Conditions/27375911.html
The Cigna Group has expanded its community impact strategy with a new three-year, $31.5 million commitment from The Cigna Group Foundation. This initiative focuses on youth mental health, veteran well-being, and supporting individuals with complex health conditions and their caregivers, combining grant funding with employee volunteerism. Nonprofits in ten states can apply for grants, with an initial focus on autoimmune, inflammatory, blood, cancer, neurological, and rare diseases.

The Cigna Group (CI) Commits $31.5M Over Three Years to Community Programs

https://www.tradingview.com/news/tradingview:463fa5a1bdb34:0-the-cigna-group-ci-commits-31-5m-over-three-years-to-community-programs/
The Cigna Group Foundation plans to invest $31.5 million over three years, starting in 2027, to support three community health commitments. This initiative builds on its refreshed 2024 strategy, which has already seen over $30 million invested in nearly 190 nonprofits. The commitment extends the Foundation's existing community engagement without altering the company's financial outlook.

Cigna Group Foundation making $31.5M in grants available to community organizations in 10 states

https://www.fiercehealthcare.com/payers/cigna-group-foundation-making-315m-grants-available-community-organizations-10-states
Cigna is making $31.5 million in grant funding available over the next three years to nonprofits in 10 states through its Cigna Group Foundation. The grants will focus on youth mental health, veteran wellness, and support for patients with complex health needs and their caregivers, with $10.5 million allocated to each area. Eligible organizations can apply for two-year, $250,000 grants to support programs in Arizona, Connecticut, Florida, Georgia, Illinois, Missouri, New Jersey, Pennsylvania, Tennessee, and Texas.

Health Insurers Sink on Sanders’ Medicare for All Plan

https://www.bloomberg.com/news/articles/2026-11-19/health-insurers-sink-on-sanders-medicare-for-all-plan
US health insurance stocks experienced a significant downturn following announcements of new federal audits for Medicare and Senator Bernie Sanders' proposals for expanded Medicare eligibility. UnitedHealth Group Inc., the largest insurer, saw its shares drop by as much as 21%, wiping out almost all its year-to-date gains due to these developments.

The Cigna Group Deepens Community Impact Strategy, Adds New Commitment Supporting People with Complex Health Conditions

https://www.prnewswire.com/news-releases/the-cigna-group-deepens-community-impact-strategy-adds-new-commitment-supporting-people-with-complex-health-conditions-302946002.html
The Cigna Group is expanding its community impact strategy with a $31.5 million commitment over three years from The Cigna Group Foundation. This initiative focuses on supporting youth mental health, veteran well-being, and individuals with complex health conditions and their caregivers, leveraging both grant funding and employee volunteerism. The grants will benefit nonprofits in ten states, with applications now open for organizations supporting complex care patients.
Advertisement

RBC Capital maintains Cigna Group at Outperform, raises price target to $346 from $337

https://www.tradingview.com/news/tradingview:b685eec4ebd31:0-rbc-capital-maintains-cigna-group-at-outperform-raises-price-target-to-346-from-337/
RBC Capital has maintained its "Outperform" rating on Cigna Group (CI) and increased its price target from $337 to $346, representing a 2.7% increase. This new target suggests a 21.2% upside from the stock's closing price of $285.37 on November 18. Other analysts have recently issued price targets for Cigna ranging from $304 to $390.

93% of private Medicare plans offered by eHealth cover a drug for obesity in 2027, if patients qualify; 5% did in 2026.

https://www.stocktitan.net/news/EHTH/medicare-annual-enrollment-halftime-report-75-of-enrollees-have-used-fonfcd4e7lml.html
A new eHealth report reveals that 75% of Medicare beneficiaries used AI tools to review their 2027 plan options. Notably, 93% of eHealth's 2027 Medicare Advantage plans now cover at least one GLP-1 drug for obesity, a significant increase from 5% in 2026. Despite technological assistance, cost remains a concern, with 63% of beneficiaries surprised by high monthly premiums and an 8% increase in average out-of-pocket maximums for selected plans.

Medicare Annual Enrollment Halftime Report: 75% of enrollees have used AI tools to review 2027 Medicare plans

https://uk.finance.yahoo.com/news/medicare-annual-enrollment-halftime-report-140000337.html
A new eHealth report reveals that 75% of Medicare beneficiaries who reviewed their 2027 plan options utilized AI tools, although licensed insurance agents remain the primary choice for plan selection. The report also highlights a significant increase in Medicare Advantage plans offered by eHealth covering GLP-1 drugs for obesity and growing optimism about healthcare affordability post-mid-term elections, despite concerns about rising premiums and out-of-pocket costs.

Modular Medical Secures Coverage Agreements with All Three of the Nation's Largest PBMs for Pivot Insulin Delivery System

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/modular-medical-secures-coverage-agreements-with-all-three-of-the-nat-1253503
Modular Medical, Inc. announced agreements with the remaining two of the nation's three largest pharmacy benefit managers (PBMs) for its Pivot™ tubeless patch pump, establishing broad coverage across commercial, Medicare, and Medicaid plans. These agreements, which cover over 182 million lives and approximately 80% of U.S. prescription claims, are a significant milestone for the company's full commercial launch and aim to increase patient access and affordability for insulin pump therapy. The company believes this will help reduce traditional coverage barriers and support the transition from multiple daily injections to advanced pump therapy.

DaVita Inc. (DVA) Stock forecasts

https://sg.finance.yahoo.com/research/reports/ARGUS_3796_QuantitativeReport_1794960000000
Argus has lowered its target price for DaVita Inc. (DVA) to $164.00, citing the company's position as the largest provider of dialysis services in the U.S. with about 35% market share. The current stock price for DVA is $156.34. The report was published on November 18, 2026.
Advertisement

Humana (HUM) Stock Trending After Hours as CMS Proposes $90B Medicare Anti-Fraud Rule

https://www.benzinga.com/markets/equities/26/11/63417422/humana-shares-slip-after-hours-cms-fraud-rule
Humana (HUM) shares were trending after hours, slipping 0.46% following the Centers for Medicare & Medicaid Services (CMS) proposal of a new anti-fraud rule. This rule, which targets fraud, waste, and abuse across several healthcare programs, could save taxpayers nearly $90 billion over 10 years. For insurers like Humana, the primary change involves stricter Medicare Advantage Risk Adjustment Data Validation audits to recover improper payments.

McKesson Corporation (MCK) Stock Forecasts

https://ca.finance.yahoo.com/research/reports/ARGUS_3176_AnalystReport_1794855055000
Argus analyst David H. Toung has raised the target price for McKesson Corporation (MCK) stock, maintaining a "Buy" rating. The report, published on November 16, 2026, highlights McKesson's operations across North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical segments.

Cigna Group falls 3.02% in Wednesday's session

https://www.globalbankingandfinance.com/cigna-group-ci-falls-2026-11-18/
Cigna Group's shares declined by 3.02% to 285.18 USD in Wednesday's trading session on November 18, 2026. The company's market capitalization stood at $75.36 billion within the United States health care sector. This decline compares the last traded price to its previous close of 294.06 USD.

Healthcare stocks (UnitedHealth, Humana, CVS, Cigna) fall on new Medicare rules

https://beinsure.com/news/healthcare-stocks-fall-as-medicare-rules-trigger-a-selloff/
Shares of major healthcare insurers like UnitedHealth, Humana, CVS Health, and Cigna Group dropped following new Medicare rules proposed by the Centers for Medicare & Medicaid Services (CMS). These stricter oversight measures, particularly expanded Medicare Advantage audits and retrospective payment recoveries, raised concerns about future profitability, with CMS estimating potential federal budget savings of nearly $90 billion. While investment banks maintain generally positive price targets, the selloff highlights investor apprehension regarding regulatory challenges and their impact on earnings.

Few payers are ready for looming electronic prior authorization deadline

https://www.techtarget.com/healthcarepayers/news/366654651/Few-payers-are-ready-for-looming-electronic-prior-authorization-deadline
A new survey by the Workgroup for Electronic Data Interchange (WEDI) reveals that only 1 in 10 payers are fully prepared to implement the electronic prior authorization requirements mandated by a 2024 regulation, despite a January 1 deadline. Payers are facing significant challenges with system connectivity, workflow adaptation, and higher-than-anticipated costs for compliance with the API requirements. While most payers are at least halfway there, providers are also largely unprepared, highlighting the complexity and cost of the new interoperability rules.
Advertisement

UnitedHealth, Humana and Elevance fall sharply after Medicare audit proposal

https://www.quantisnow.com/articles/cms-audit-proposal-drives-humana-unitedhealth-and-elevance-lower-as-s-p-500-edges-up
UnitedHealth, Humana, and Elevance Health experienced significant stock declines following a CMS proposal to extend Medicare Advantage audit recoveries back to 2018. The proposal, which could amount to roughly $9 billion per payment year, led to a combined paper loss of about $43 billion for the three companies by early afternoon on November 18, 2026. Analysts expect potential legal challenges to the rule, with Oppenheimer suggesting recoveries may be concentrated later and priced into future bids.

UnitedHealth and Humana fall after CMS proposes a $90 billion anti-fraud rule

https://mlq.ai/news/unitedhealth-and-humana-fall-after-cms-proposes-a-90-billion-anti-fraud-rule/
Shares of UnitedHealth Group, Humana, CVS Health, and Cigna fell after the Centers for Medicare & Medicaid Services (CMS) proposed a new Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) rule. This rule aims to recover an estimated $90 billion over 10 years through tougher audits of Medicare Advantage insurers, extrapolating audit findings and requiring reporting of suspected fraud. The proposal, scheduled for publication on November 19, 2026, is open for comments until January 19, 2027, and follows a previous court setback for similar provisions.

Florida Seniors and Primary Care Providers Agree that Prevention, Affordable Care and Comprehensive Coverage are Keys to Healthy Aging

https://www.quantisnow.com/insight/florida-seniors-and-primary-care-providers-agree-that-prevention-affordable-6798307
Humana commissioned two Morning Consult surveys of Florida seniors and primary care providers, highlighting affordability, prevention, supplemental benefits, and coordinated care as top priorities for healthy aging. The surveys suggest strong retention for Medicare Advantage plans, with 97% of current enrollees planning to stay. However, both providers and seniors identified out-of-pocket and prescription drug costs as significant barriers.

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina

https://www.theglobeandmail.com/investing/markets/stocks/UNH/pressreleases/8894263/zacks-industry-outlook-highlights-unitedhealth-the-cigna-humana-centene-and-molina/
The U.S. health insurance (HMO) industry faces both opportunities and challenges, with diversified health plans and an aging population supporting membership and demand for Medicare. Regulatory changes like Medicaid eligibility checks and expired ACA subsidies threaten enrollment, while technological advancements like AI and telehealth improve efficiency but carry implementation costs. Industry leaders like UnitedHealth Group, Cigna, Humana, Centene, and Molina Healthcare are well-positioned to leverage these dynamics, supported by strategic acquisitions and an optimistic Zacks Industry Rank.

UnitedHealth Shares Slide 5.4% Amid Scrutiny Over Conglomerate Structure and Medicare Oversight

https://news.jkn.co.kr/editions/english/post/1103124
UnitedHealth Group Inc. shares dropped 5.42% following renewed calls from Senator Elizabeth Warren to break up major healthcare conglomerates with the proposed Break Up Big Medicine Act. This legislative push, coupled with the Centers for Medicare & Medicaid Services proposing the CRUSH rule to tighten Medicare Advantage regulations, intensified scrutiny on UnitedHealth's integrated business model. Despite strong third-quarter earnings, the company's stock underperformed the market.
Advertisement

UnitedHealth Group falls 5.42% in Tuesday's session

https://www.globalbankingandfinance.com/unitedhealth-group-unh-falls-2026-11-17/
UnitedHealth Group shares experienced a significant drop, trading 5.42% below their previous close at $389.68 on November 17, 2026. The company's market capitalization stood at $353.89 billion in the United States health care sector. This decline was reported after the market closed, with the last traded price differing from the exchange's official closing price.

$100 Invested In Cigna Group 20 Years Ago Would Be Worth This Much Today

https://www.benzinga.com/news/26/11/63367275/100-invested-cigna-group-20-years-ago-would-be-worth-much-today
Cigna Group (NYSE: CI) has outperformed the market over the past two decades with an average annual return of 10.26%. An initial investment of $100 in Cigna stock 20 years ago would now be valued at $704.92, based on the current price of $293.45. This highlights the significant impact of compounded returns on investment growth over time.

CVS Health Stocks Fall 3.12% as Aetna Faces Tougher Medicare Advantage Audit Rules

https://www.tradingview.com/news/gurufocus:8e8a46678094b:0-cvs-health-stocks-fall-3-12-as-aetna-faces-tougher-medicare-advantage-audit-rules/
CVS Health shares dropped 3.12% after the Department of Health and Human Services proposed new rules to toughen audits of Medicare Advantage plans, including CVS's Aetna unit. The proposed rule would allow CMS to extrapolate risk adjustment audit results across entire contracts, impacting managed care companies. Despite CVS having a diversified business with pharmacy and benefits, investors are awaiting management's exposure estimates regarding the potential impact of these new regulations.

Cigna Group stock outperforms competitors despite losses on the day

https://www.marketwatch.com/data-news/cigna-group-stock-outperforms-competitors-despite-losses-on-the-day-15ffd28f-0354a707d02a?mod=goog_fin_scmw
Shares of Cigna Group (CI) fell 2.03% to $294.06 on Tuesday, despite outperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average decline more significantly. This drop ended a two-day winning streak for the company's stock.

UnitedHealth Stock Drops 4%: What’s Going On?

https://www.benzinga.com/trading-ideas/movers/26/11/63348762/unitedhealth-stock-drops-4-whats-going-on
UnitedHealth Group (NYSE:UNH) shares dropped after Senator Elizabeth Warren called for breaking up major healthcare conglomerates, including UnitedHealth, citing concerns over their vertical integration and influence on patient care. Concurrently, the Centers for Medicare & Medicaid Services (CMS) proposed new "CRUSH" rules to combat healthcare fraud, waste, and abuse, further impacting the sector. These combined pressures led to a significant decline in UnitedHealth's stock price.
Advertisement

Elizabeth Warren Targets CVS, UnitedHealth and Cigna, Says Healthcare Giants ‘Take a Cut at Every Step’ as She Calls for Breaking Up Conglomerates

https://www.benzinga.com/news/health-care/26/11/63331289/elizabeth-warren-targets-cvs-unitedhealth-and-cigna-says-healthcare-giants-take-a-cut-at-every-step-as-she-calls-for-breaking-up-conglomerates
Senator Elizabeth Warren is advocating for the breakup of major healthcare conglomerates like CVS Health Corp, UnitedHealth Group Inc., and The Cigna Group, arguing they "take a cut at every step" due to their vertical integration. Her "Break Up Big Medicine Act" would prevent health insurers, PBMs, and wholesale drug distributors from owning healthcare providers. Warren's proposal targets the broad influence of these companies across pharmacy, insurance, and patient care, challenging their business structures and acquisitions.

Learn Why The Bull Case For Cigna Group Stock Could Change Following Quarterly Earnings

https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/learn-why-the-bull-case-for-cigna-group-stock-could-change-f
Cigna Group reported mixed Q3 2026 results with higher sales and revenue but lower net income, raising concerns about cost trends and margin pressure. Investors will closely scrutinize commentary from Cigna Group's CFO at the upcoming UBS Global Healthcare Conference for insights into business drivers and strategies to address profitability. The article highlights the tension between strong cash flows from Evernorth and Cigna Healthcare and the ongoing regulatory and cost pressures affecting the company's profitability.

OpenAI Unveils AI Agent That Directly Operates Hospital Systems, Adopted by CVS and Cigna

https://finance.biggo.com/news/f3508053-23b9-4796-85eb-9a9c8f6a168b
OpenAI has launched a "ChatGPT for Healthcare" update featuring an AI agent capable of directly interacting with hospital and insurer software to automate administrative tasks like preparing MRI orders and prior-authorization forms. This agent has been adopted by CVS Health and Cigna Healthcare, significantly reducing backlogs and information search times. The update also includes improved clinical search features and expanded plugin support from various healthcare companies, shifting medical AI's focus from diagnostic assistance to administrative automation.

Florida fines 13 pharmacy benefit managers $12.66 million, including a CVS-affiliated company

https://www.medicaldaily.com/florida-fines-13-pbms-12-66-million-481271
Florida has levied $12.66 million in fines against 13 pharmacy benefit managers (PBMs), including a CVS Health company, for violating state laws related to fair pricing, network adequacy, and pharmacy contracts. These penalties are the result of market conduct examinations under Florida's Prescription Drug Reform Act, with several companies contesting the findings. Regulators are pressing for greater transparency and accountability from PBMs, warning of further enforcement for non-cooperation.

Is Cigna Group (CI) Below Fair Value On Mixed Q3 2026 Earnings?

https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/is-cigna-group-ci-below-fair-value-on-mixed-q3-2026-earnings
Cigna Group (CI) released mixed Q3 2026 earnings, reporting higher sales and revenue but lower net income and EPS. Despite recent share gains, the stock trades below analyst targets and appears significantly undervalued, with a narrative fair value estimate of $636.28 against its closing price of $297.00. The perceived undervaluation is attributed to market concerns regarding political hostility towards PBMs, regulatory monitoring of Express Scripts, and other operational uncertainties, reducing the actionable margin of safety.
Advertisement

Wells Fargo raises Cigna stock price target to $325 on valuation

https://www.investing.com/news/analyst-ratings/wells-fargo-raises-cigna-stock-price-target-to-325-on-valuation-93CH-5024729
Wells Fargo increased its price target for Cigna (NYSE:CI) shares to $325 from $307, maintaining an Equal Weight rating, despite lowering its 2027 and 2028 EPS estimates. This adjustment reflects less discounting applied to future earnings and Cigna's reiteration of at least 10% EPS growth for 2027. The article also notes mixed analyst sentiment following Cigna's strong Q3 2026 results, with Piper Sandler lowering its target due to rebate pool concerns while Bernstein SocGen Group raised its target.

3 US Defensive Dividend Stocks For Higher Rates and Steady Cash Flow

https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/3-us-defensive-dividend-stocks-for-higher-rates-and-steady-c
This article identifies three US large-cap defensive dividend stocks – Elevance Health (ELV), Becton Dickinson (BDX), and Cigna Group (CI) – that are well-positioned for an environment of higher interest rates due to their steady cash flows and essential services. These companies operate in healthcare, providing recurring revenue through premiums, medical supplies, and pharmacy benefits, which support consistent dividend payments. The analysis also briefly touches on potential challenges each company might face, such as rising utilization costs or pricing pressures.

UnitedHealth vs. Cigna: Which Dividend Stock Pays You More in 10 Years?

https://www.tikr.com/blog/unitedhealth-vs-cigna-which-dividend-stock-pays-you-more-in-10-years
This article compares the dividend potential of UnitedHealth Group (UNH) and Cigna Group (CI) over a 10-year period. While UnitedHealth currently offers a higher yield and is projected to pay slightly more over the decade, Cigna boasts a lower cash dividend payout ratio, indicating greater flexibility for future dividend increases. Both companies recently affirmed their quarterly dividends and provided optimistic earnings outlooks for the coming years.

Wells Fargo maintains Cigna Group at Equal-Weight, raises price target to $325 from $307

https://www.tradingview.com/news/tradingview:95fddc5c0f238:0-wells-fargo-maintains-cigna-group-at-equal-weight-raises-price-target-to-325-from-307/
Wells Fargo has maintained its "Equal-Weight" rating for Cigna Group (CI) and increased its price target from $307 to $325, representing a 5.9% increase. This new price target suggests a 9.7% upside from Cigna's closing price of $296.27 on November 12. Other analysts have recently issued price targets ranging from $304 to $390 for Cigna Group.

Wells Fargo raises Cigna stock price target to $325 on valuation

https://ca.investing.com/news/stock-market-news/wells-fargo-raises-cigna-stock-price-target-to-325-on-valuation-93CH-4956071
Wells Fargo increased its price target for Cigna stock to $325 from $307, maintaining an Equal Weight rating, despite lowering its 2027 and 2028 earnings per share estimates. This adjustment is due to less discounting applied to future earnings, with Cigna reiterating at least 10% EPS growth for 2027. The article also notes mixed analyst sentiment, with Piper Sandler lowering its target due to rebate pool contraction, while Bernstein SocGen Group raised its target, expressing confidence in Cigna's growth outlook.
Advertisement

UnitedHealth releases 'independent review' of its medical policies

https://healthexec.com/topics/healthcare-management/business-intelligence/unitedhealth-releases-independent-review-its-medical-policies
UnitedHealth Group has completed an "independent review" of its medical policy development and maintenance processes, initiated due to leadership changes and investor lawsuits. The report by FTI Consulting and Rubrum Advising found UnitedHealthcare has a strong, industry-leading approach, though it identified areas for improvement in documentation. CEO Steve Hemsley welcomed the findings, stating they will be used to further strengthen processes.

Boys & Girls Clubs of America and The Cigna Group Foundation Advance Youth Mental Health Together

https://www.bgca.org/news-stories/2026/November/boys-girls-clubs-of-america-and-the-cigna-group-foundation-advance-youth-mental-health-together/
Boys & Girls Clubs of America (BGCA) and The Cigna Group Foundation are collaborating to enhance youth mental health support by creating trauma-informed environments and developing new resources for teens and staff. This partnership, which began in 2024, has equipped over 11,000 staff members with evidence-informed training and involved Cigna Group employees in more than 2,000 volunteer hours. The initiative aims to provide young people with essential skills, supportive relationships, and tools for emotional well-being.

Cigna Group (NYSE:CI) Price Target Raised to $304.00

https://www.marketbeat.com/instant-alerts/analyst-cigna-group-nyse-ci-price-target-raised-to-30400-2026-11-12/
Jefferies Financial Group raised its price target for Cigna Group (NYSE:CI) to $304.00 from $288.00, maintaining a "hold" rating, which suggests a modest 2.54% upside. This follows Cigna's strong quarterly earnings report, where it surpassed analyst expectations with adjusted earnings of $7.98 per share and revenue of $73.79 billion. Despite the positive earnings, Cigna's shares experienced a slight dip, trading down 1.7% to $296.47 on Thursday.

Learn Why The Bull Case For Cigna Group (CI) Could Change Following Higher EPS Outlook

https://ca.finance.yahoo.com/news/learn-why-bull-case-cigna-021523270.html
Cigna Group recently reported strong third-quarter 2026 revenue and net income, projecting 10% to 14% annual adjusted EPS growth through 2030, supported by a US$3 billion modernization program. This outlook, coupled with improved pre-tax adjusted income from its Specialty and Care Services unit, is reshaping the investment narrative for the company. While the company faces regulatory and litigation risks, its long-term growth framework and modernization efforts are key factors for investors to consider.

Jefferies maintains Cigna Group at Hold, raises price target to $304 from $288

https://www.tradingview.com/news/tradingview:7fb066100251f:0-jefferies-maintains-cigna-group-at-hold-raises-price-target-to-304-from-288/
Jefferies has maintained its "Hold" rating for Cigna Group (CI) while increasing its price target from $288 to $304, a 5.6% raise. This new target is closely aligned with Cigna's closing price of $301.45 on November 11. Recent analyst actions on Cigna Group have seen price targets ranging from $320 to $390 over the last 30 days.
Advertisement

UnitedHealth audit of insurer policies ducks question of denials

https://www.healthcaredive.com/news/unitedhealth-internal-review-medical-policies-gaps-denials/874454/
UnitedHealth released an audit of its insurance unit, UnitedHealthcare, focusing on how it creates clinical criteria for coverage decisions. While the audit found minor issues with policy development, it crucially omitted how these policies are applied, a point of contention for regulators and a concern for the 48 million members whose care could be denied. This omission is significant given past research indicating many UnitedHealthcare denials are overturned on appeal, and ongoing scrutiny from lawmakers and the Department of Justice regarding the company's coverage practices.

Cigna Group stock underperforms Thursday when compared to competitors

https://www.marketwatch.com/data-news/cigna-group-stock-underperforms-thursday-when-compared-to-competitors-65952600-1be477629dca?mod=goog_fin_scmw
Cigna Group (CI) stock declined 1.72% on Thursday, closing at $296.27. This underperformance occurred during a generally negative trading session for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also experiencing declines. The stock's drop marked its second consecutive day of losses.

Why Does VFLO Hold More Healthcare Than Its Value Benchmark?

https://etfdb.com/free-cash-flow-content-hub/vflo-hold-more-healthcare-benchmark/
The VictoryShares Free Cash Flow ETF (VFLO) holds a larger percentage in healthcare companies than its benchmark, the Russell 1000® Value Index, not due to a sector call but because healthcare companies generate significant free cash flow. VFLO's underlying index ranks companies based on free cash flow yield and growth, leading to a higher allocation in sectors like healthcare, energy, and information technology compared to traditional value benchmarks. This distinct sector exposure, including the absence of financials, results in a different portfolio composition and a lower forward price-to-earnings ratio for VFLO.

Can CVS Health's 2028 Split Unlock Value Despite Execution Risks?

https://www.tradingview.com/news/zacks:eae603900094b:0-can-cvs-health-s-2028-split-unlock-value-despite-execution-risks/
CVS Health plans to separate into two publicly traded companies by the first half of 2028, aiming to sharpen strategic focus and improve capital allocation. While the split could offer greater operating flexibility and dedicated leadership, it faces risks such as restructuring costs, dis-synergies, and management distraction over a lengthy implementation period. Investors must weigh these strategic benefits against potential execution challenges given the long timeline and ongoing business initiatives.

Piper Sandler maintains Cigna Group at Overweight, lowers price target to $360 from $370

https://www.tradingview.com/news/tradingview:d185220ca4b64:0-piper-sandler-maintains-cigna-group-at-overweight-lowers-price-target-to-360-from-370/
Piper Sandler has maintained its "Overweight" rating on Cigna Group but reduced its price target from $370 to $360, representing a 2.7% decrease. This new price target implies a 19.4% upside from Cigna's closing price of $301.45 on November 11. Other analysts have recently issued price targets for Cigna ranging from $320 to $390.
Advertisement

Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle

https://sg.news.yahoo.com/takeda-launches-sleep-disorder-pill-123750635.html
Takeda has launched Orzeyful, its narcolepsy pill, in the U.S. after receiving Schedule IV controlled substance classification from the DEA. The drug is the first treatment to target the underlying cause of narcolepsy type 1 by addressing the loss of orexin signaling, rather than just symptoms. Orzeyful, which has a list price of $16,500 per 60-tablet bottle, is now available by prescription through Cigna's Accredo Specialty Pharmacy.

Corebridge Financial Inc. (CRBG) Stock Forecasts

https://ca.finance.yahoo.com/research/reports/ARGUS_6761_QuantitativeReport_1794355200000
Argus has issued a HOLD rating for Corebridge Financial Inc. (CRBG), with a price target of $38.00. The report details subratings including High for Industry, Low for Management and Growth, Medium for Safety and Financial Strength, and High for Value. The current price of CRBG stock is $36.12.

How The Cigna Group and Sierra are connecting the health care experience

https://sierra.ai/customers/the-cigna-group
The Cigna Group and Sierra are collaborating to create a more connected and personalized healthcare experience through the strategic use of AI. The Cigna Group is leveraging its health intelligence capability, combining data, AI, and clinical expertise, while Sierra provides conversational AI technology to accelerate these efforts. This partnership aims to improve outcomes, enhance affordability, and reduce administrative burdens for customers, employers, and plan sponsors by making interactions simpler and more efficient.

Bernstein raises Cigna stock price target on 2027 growth outlook

https://www.investing.com/news/analyst-ratings/bernstein-raises-cigna-stock-price-target-on-2027-growth-outlook-93CH-5018268
Bernstein SocGen Group has increased its price target for Cigna Group stock from $387 to $390, maintaining an Outperform rating due to the company's consistent 2027 growth outlook. The firm believes Cigna's multiple should settle around 12-13x over the next few years, anticipating strong execution to rebuild investor confidence and drive earnings durability. This adjustment follows Cigna's strong Q3 2026 results, where it surpassed analyst expectations for earnings and revenue, and raised its full-year earnings outlook.

Cigna Group Targets $45 EPS by 2030 as Specialty Growth Offsets Pharmacy Headwinds

https://finance.yahoo.com/healthcare/articles/cigna-group-targets-45-eps-071431141.html
Cigna Group aims for at least $45 EPS by 2030, driven by its specialty business which is projected to grow 8%–12% and constitute 40% of earnings by that year. This growth is expected to offset headwinds in its pharmacy benefit services, particularly from reduced employer coverage of GLP-1 drugs and shrinking rebate pools, with 2027 anticipated as a trough year for the pharmacy segment. Cigna's new Signature pharmacy model, rolling out in 2027 and 2028, is expected to help the pharmacy benefit services return to growth after 2027.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement